PORTFOLIO
PROJECTS
We specialize in investment portfolios in innovations for health advancement & life improvement. The president of the company, Mr Roar Adelsten is an entrepreneur, who has, over his years, focused on companies in these industries.
The vast experience of Mr Roar Adelsten makes it possible for him to find innovative objects and medical research with great potential.
OUR COMPANIES
AUXESIS PHARMA AB (publ)
Auxesis Pharma Holding AB was founded in 2019 as a Life Science Innovation company interdisciplinary in the medical industry and is the parent company of CoxyPet Pharma AB.
AUXESIS PHARMA HOLDING AB (publ) is the holder of research knowledge and all immaterial rights for the global market.
COXYPET PHARMA AB
CoxyPet Pharma AB was established in 2018 to be able to enter the animal care sector. The aim for CoxyPet Pharma AB is to develop pain elimination products for the animal care markets such as; veterinary, household pets, cattle industry, horseracing, camelrace, dograces etc.
INVESTING IN MEDICAL life science
RESEARCH & SOLUTION
AUXESIS PHARMA HOLDING AB (publ) is a company that owns the rights of any additional and necessary patents in a specific medical research area.
The research, which is ongoing, aims to develop several extremely fast medical analgesic preparations.
CLINICAL STUDIES
The global challenge today is quick pain relief for topical exposure and infections from sun burn, wasp and mosquito bites, herpes, nettle, jelly fish etc. The pain relief is immediate and today there is no corresponding drug on the medical market.
ASA.P® is a non-prescription topical pain elimination solution that can be applied to the skin in different forms.
INNOVATION & PRODUCTION
ASA.P® is a non-prescription topical pain elimination drug that can be applied to the skin in different forms. Our research reveals that it drastically diminishes pain caused by insect bites, poison plants, rashes, eczema, herpes etc in its own, unique way.
Therefore, we believe ASA.P® has all the requirements to be a unique and profitable product for the growing topical pain market.
